An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2010-07-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2010.05.010PMID 20639113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.

  2009cited by this paper
• MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia.

  2009cited by this paper
• A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor.

  2009cited by this paper
• The conformational flexibility of the carboxy terminal residues 105-114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor.

  2008cited by this paper
• The chemical versatility of the β–α–β fold: Catalytic promiscuity and divergent evolution in the tautomerase superfamily

  2008cited by this paper
• A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.

  2008cited by this paper
• [Inhibition effect of MIF antibody on the growth of hepatocellular carcinoma cell HepG2 in vitro].

  2008cited by this paper
• Nat. Rev. Drug Disc.

  2007cited by this paper
• Regulation of Human Lung Adenocarcinoma Cell Migration and Invasion by Macrophage Migration Inhibitory Factor*

  2007cited by this paper
• Alternative Chemical Modifications Reverse the Binding Orientation of a Pharmacophore Scaffold in the Active Site of Macrophage Migration Inhibitory Factor*

  2007cited by this paper
• Macrophage migration inhibitory factor: a probable link between inflammation and cancer.

  2007cited by this paper
• Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders.

  2006cited by this paper
• MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

  2006cited by this paper
• Interpreting steep dose-response curves in early inhibitor discovery.

  2006cited by this paper
• A detergent-based assay for the detection of promiscuous inhibitors

  2006cited by this paper
• Importance of the CMAP correction to the CHARMM22 protein force field: dynamics of hen lysozyme.

  2006cited by this paper
• Inhibition of Macrophage Migration Inhibitory Factor or Its Receptor (CD74) Attenuates Growth and Invasion of DU-145 Prostate Cancer Cells1

  2006cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Some insights into the stereochemistry of inhibition of macrophage migration inhibitory factor with 2-fluoro-p-hydroxycinnamate and its analogues from molecular dynamics simulations.

  2005cited by this paper
• ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis*

  2005cited by this paper
• How glucocorticoids control their own strength and the balance between pro‐ and anti‐inflammatory mediators.

  2005cited by this paper
• The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis

  2005cited by this paper
• Empirical force fields for biological macromolecules: Overview and issues

  2004cited by this paper
• Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations

  2004cited by this paper
• Macrophage migration inhibitory factor: a regulator of innate immunity

  2003cited by this paper
• Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine.

  2003cited by this paper
• Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites

  2002cited by this paper
• Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice.

  2002cited by this paper
• Consensus scoring for ligand/protein interactions.

  2002cited by this paper
• The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents*

  2002cited by this paper
• The 4-oxalocrotonate tautomerase family of enzymes: how nature makes new enzymes using a beta-alpha-beta structural motif.

  2002cited by this paper
• The 4-oxalocrotonate tautomerase family of enzymes: How nature makes new enzymes using a β-α-β structural motif

  2002cited by this paper
• Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.

  2002cited by this paper
• Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.

  2002cited by this paper
• Expression of Macrophage Migration Inhibitory Factor in Human Breast Cancer: Association with Nodal Spread

  2002cited by this paper
• Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery.

  2001cited by this paper
• Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography.

  2001cited by this paper
• Macrophage Migration Inhibitory Factor Up-regulates Expression of Matrix Metalloproteinases in Synovial Fibroblasts of Rheumatoid Arthritis*

  2000cited by this paper
• Protection from septic shock by neutralization of macrophage migration inhibitory factor

  2000cited by this paper
• Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.

  1999cited by this paper
• Serum MMP-3 in rheumatoid arthritis: correlation with systemic inflammation but not with erosive status.

  1999cited by this paper
• Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF)

  1999cited by this paper
• Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.

  1999cited by this paper
• Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein.

  1999cited by this paper
• Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor.

  1998cited by this paper
• Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor

  1998cited by this paper
• All-atom empirical potential for molecular modeling and dynamics studies of proteins.

  1998cited by this paper
• Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion

  1997cited by this paper
• Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes

  1997cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• Placement of medium-sized molecular fragments into active sites of proteins

  1996cited by this paper
• The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer.

  1996cited by this paper
• NMR characterization of structure, backbone dynamics, and glutathione binding of the human macrophage migration inhibitory factor (MIF)

  1996cited by this paper
• A fast flexible docking method using an incremental construction algorithm.

  1996cited by this paper
• Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor.

  1996cited by this paper
• An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

  1996cited by this paper
• Catalytic role of the amino-terminal proline in 4-oxalocrotonate tautomerase: affinity labeling and heteronuclear NMR studies.

  1996cited by this paper
• MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

  1995cited by this paper
• Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

  1995cited by this paper
• Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).

  1994cited by this paper
• The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

  1994cited by this paper
• MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

  1993cited by this paper
• Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.

  1993cited by this paper
• Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells.

  1992cited by this paper
• Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani.

  1991cited by this paper
• A geometric approach to macromolecule-ligand interactions.

  1982cited by this paper
• Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes

  1977cited by this paper
• Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

  1966cited by this paper
• Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity

  1966cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Identification of Macrophage Migration Inhibitory Factor as a Potent Endothelial Cell Growth-Promoting

  year unknowncited by this paper

• Beware of N-Benzoyloxybenzamides

  2024cites this paper
• Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein-Protein Interaction: A Semi-Automated "Hit Identification-to-Optimization" Approach.

  2023cites this paper
• Underrepresented Impurities in 4-Hydroxyphenylpyruvate Affect the Catalytic Activity of Multiple Enzymes.

  2023cites this paper
• Discovery of small molecule inhibitors of the PTK7/β-catenin inter-action targeting the Wnt signaling pathway in colorectal cancer

  2021cites this paper
• Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

  2018cites this paper
• The immunotoxicity of aluminum trichloride on rat peritoneal macrophages via β2-adrenoceptors/cAMP pathway acted by norepinephrine.

  2016cites this paper
• Irregularities in enzyme assays: The case of macrophage migration inhibitory factor.

  2016cites this paper
• Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer.

  2015cites this paper
• MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus

  2015cites this paper
• Virtual Screening of Some Active Human Macrophage Migration Inhibitory Factor Antagonists

  2014cites this paper
• Crystallographic and Receptor Binding Characterization of Plasmodium falciparum Macrophage Migration Inhibitory Factor Complexed to Two Potent Inhibitors

  2014cites this paper
• Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays.

  2014cites this paper
• Recent advances in computer-aided drug design as applied to anti-influenza drug discovery.

  2014cites this paper
• Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitors.

  2013cites this paper
• Current developments of macrophage migration inhibitory factor (MIF) inhibitors.

  2013cites this paper
• Ligand Pose and Orientational Sampling in Molecular Docking

  2013cites this paper
• Structure-based discovery of anti-influenza virus A compounds among medicines.

  2012cites this paper